Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australian & New Zealand Urogenital and Prostate Cancer Trials Group Limited (ANZUP)
Scientific Title
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer